New hope against tuberculosis: spectinamides
Tuberculosis (TB) represents a serious public health problem. The latest reports estimate an incidence of 8.7 million cases in 2001 and over 1.4 million deaths per year. The disease is usually be treated with a first-line drugs, isoniazid and rifampin, the two most potent anti-tuberculosis agents. However, the prevalence of multidrug-resistant (MDR) tuberculosis cause by […]